Evidence from a dual action of converting enzyme inhibitor on blood pressure in normal man
Authors:
- Robert GoldstoneRGRobert Goldstone
- Keith MartinKMKeith Martin
- Robert ZipserRZRobert Zipser
- Richard HortonRHRichard Horton
- 1 October 1981
- journal article
- Published by Elsevier in Prostaglandins
- Vol. 22 (4) , 587-598
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effect of prostaglandin inhibition on the hypertensive action of sodium-retaining steroids.Hypertension, 1981
- Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.Hypertension, 1981
- Implication of Endogenous Prostaglandin System in the Antihypertensive Effect of Captopril, SQ14225, in Low Renin Hypertension : IX Conference on the Pathogenesis of HypertensionJapanese Circulation Journal, 1980
- The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.Hypertension, 1979
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.Hypertension, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1979
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977